SAT-086 A Rare Case of Cholestatic Liver Disease Causing Markedly Elevated LDL Successfully Managed with Plasmapheresis and Ursodeoxycholic Acid

Background Hypercholesterolemia (HC) in cholestatic liver disease commonly involves a high lipoprotein-X (LpX) and low LDL receptors. No evidence has been found to suggest the association of LpX with an increased risk of cardiovascular disease (CVD). Hence, lipid lowering therapy is unnecessary as H...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yee Liong, Prado, Victor, Kheng Joe, Lau, Go, Muriel Tania, Anaya Noubleau, Axa Maria, Mascarell, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552154/
http://dx.doi.org/10.1210/js.2019-SAT-086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552154/
http://dx.doi.org/10.1210/js.2019-SAT-086

Ejemplares similares